Compare Cenovus Energy Inc (CVE) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cenovus Energy Inc vs Oscar Health Inc — how do they compare? Cenovus Energy Inc trades at $31.45 (market cap $57.90B), while Oscar Health Inc trades at $33.48 (market cap $10.22B). The key difference: Cenovus Energy Inc is far larger — about 5.7× Oscar Health Inc's market cap, and Cenovus Energy Inc pays a 1.97% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Oscar Health Inc for 15 Days on average.
| CVE | OSCR | |
|---|---|---|
Market Cap | $57.90B | $10.22B |
Volume | 7,863,588 | 4,123,394 |
Sector | Energy | Health |
52-Week High | $33.92 | $33.81 |
52-Week Low | $15.85 | $10.85 |
Typical Hold Time | 46 Days | 15 Days |
Enterprise Value | $63.84B | $6.57B |
Dividend Yield | 1.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cenovus Energy (CVE) trades at $31.53, up 2.94% with a bullish technical signal and strong institutional support. The stock shows solid fundamentals with a P/E of 12.43, net income margin of 11.48%, and consistent earnings beats in recent quarters. Recent analyst upgrades and positive media coverage highlight the company's attractive valuation and growth prospects in the energy sector.
Outlook remains positive with projected 2026 revenue of $58.0B and net income of $6.7B, though investors should monitor oil price volatility and execution risks. Analyst consensus leans bullish with 11 buy ratings versus 1 sell, while technical indicators suggest potential resistance near $32.
OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.
The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
